Table 5.

Comparison of QOL mean improvements in subjects with medically treated GERD and subjects with GERD reporting no medical treatment.

	Medically Treated GERD		Not Medically Treated GERD
QOL Improvement:	Mean (SD)	Range	Mean (SD)	Range	p-value
	(n=49)		(n=23)
RSDI physical subscale	−9.3 (9.3)	[−44, 101	−9.3 (8.4)	[−27, 11]	0.847
RSDI functional subscale	−7.7 (8.2)	[−24, 7]	−7.8 (7.8)	[−21, 7]	0.904
RSDI emotional subscale	−5.6 (8.3)	[−28, 8]	−5.7 (8.3)	[−23, 16]	0.828
RSDI total	−22.7 (23.1)	[−92, 25]	−22.9 (20.1)	[−56, 19]	0.861
	(n=27)		(n=10)
CSS symptom subscale	39.5 (27.0)	[0, 100]	34.2 (31.0)	[−17, 75]	0.880
CSS medication subscale	14.8 (26.1)	[−59, 50]	5.0 (41.2)	[−50, 100]	0.191
CSS total	27.2 (20.0)	[−17, 63]	19.6 (32.4)	[−30, 88]	0.229
	(n=22)		(n=13)
SNOT-22	−19.7 (23.3)	[−71, 27]	−23.2 (14.8)	[−47, −2]	0.724

QOL, quality of life; GERD, gastroesophageal reflux disease; SD, standard deviation; RSDI, Rhinosinusitis Disability Index; CSS, Chronic Sinusitis Survey; SNOT-22, 22-item Sinonasal Outcome Test